Related by context. Frequent words. (Click for all words.) 67 Initiates Phase II 66 Completes Enrollment 66 Cornerstone Therapeutics Inc. 64 Transcept Pharmaceuticals 64 Receives Orphan Drug Designation 64 Inc. Nasdaq SEPR 64 Presents Positive 63 Generic Version 62 Inc Therapeutic Competitors 62 Inc. Nasdaq IMGN 61 Connetics Corporation 61 gets USFDA nod 61 Company Nasdaq PRGO 61 Barrier Therapeutics Inc. 61 EPIX Pharmaceuticals Inc. 61 DRRX 60 VIA Pharmaceuticals 60 Announces Dismissal 60 FDA Accepts 60 Patient Enrollment 59 Inc. Nasdaq MYL 59 Genelabs Technologies Inc. 59 Andrx Corporation 59 Files Shelf Registration Statement 59 Nasdaq ENZN 59 Preclinical Data 59 Drug Candidate 59 ACADIA Pharmaceuticals 58 Initiates Phase 58 CRTX 58 Metabasis Therapeutics Inc. 58 NYSE MYL 58 Warner Chilcott Limited 58 Inc. NASDAQ QLTI 58 PROFILE CO 58 Inc. NASDAQ MRNA 58 NASDAQ LGND 58 Idera Pharmaceuticals 58 Nasdaq VRTX 57 Portola Pharmaceuticals 57 FDA Clears 57 Inc. NASDAQ CEPH 57 NASDAQ CYPB 57 Clinical Trial Results 57 Q3 Loss Widens 57 Q4 Loss Widens 57 Full Prescribing Information 57 NASDAQ CRXL 57 Metabasis Therapeutics 57 Single Dose 57 HAYWARD Calif. BUSINESS WIRE 57 DVAX 57 Nastech Pharmaceutical Company 57 Takeda Kyowa Hakko Kirin 57 Q2 Loss Narrows 57 Teva Pharma 57 PHARMACEUTICALS 57 Q4 Loss Narrows 56 Announces Presentation 56 Propoxyphene 56 Announces FDA Clearance 56 Cholesterol Drug 56 Report companiesandmarkets.com adds 56 Threshold Pharmaceuticals 56 Q1 Loss Narrows 56 ISTA Pharmaceuticals Inc. 56 Announces Stockholder Approval 56 THERAPEUTICS 56 EntreMed Inc. 56 IMPAX Laboratories Inc. 56 Nasdaq BDSI 56 Small Molecule 56 Q2 Loss Widens 56 Cortex Pharmaceuticals 56 NovaBay Pharmaceuticals 56 CoTherix Inc. 56 Nasdaq AMGN 55 SciClone Pharmaceuticals 55 Fibrocell Science Inc. 55 Bayhill Therapeutics 55 Somaxon Pharmaceuticals 55 Vicuron Pharmaceuticals 55 Regains Compliance 55 Completes Tender Offer 55 www.gsk.com 55 ENZN 55 Cephalon NASDAQ CEPH 55 Altus Pharmaceuticals 55 Sciele Pharma Inc. 55 Drug Application 55 Threshold Pharmaceuticals Inc. 55 LGND 55 Develop Novel 55 Nasdaq AMLN 55 ISTA Pharmaceuticals 55 Patent Infringement Lawsuit 55 Hold Fourth Quarter 55 Calls Purchased 55 Maxim Pharmaceuticals 55 RNAi Therapeutics 55 BIOTECHNOLOGY